Radspherin

· Oncoinvent Solutions AS

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Radspherin, covering 2025-08-28 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis [Phase 1]